We are live on
!
Find out more
Macquarie Group Portfolio holdings
AUM
$16.8B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
-14.21%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$89.1B
AUM Growth
+$88.9B
(+67,641%)
Cap. Flow
-$3.22B
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
11.59%
Holding
2,672
New
86
Increased
706
Reduced
853
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$324M |
| 2 |
Meta Platforms (Facebook)
META
|
+$263M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$175M |
| 4 |
NextEra Energy
NEE
|
+$132M |
| 5 |
Snap
SNAP
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$504M |
| 2 |
Apple
AAPL
|
+$433M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$248M |
| 4 |
Viatris
VTRS
|
+$241M |
| 5 |
Amazon
AMZN
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.5% |
| 4 | Industrials | 10.21% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Xylem
XYL
$28.6B
| $338K | ﹤0.01% |
4,329
-206
| -5% | -$17K |
|
1577
VEON
VEON
$3.58B
| $337K | ﹤0.01% |
29,291
| – | – |
|
1578
Palantir
PLTR
$315B
| $335K | ﹤0.01% |
36,965
-12,327
| -25% | -$122K |
|
1579
Toro Company
TTC
$9.01B
| $334K | ﹤0.01% |
4,411
| – | – |
|
|
PGRE
1580
DELISTED
Paramount Group
PGRE
| $333K | ﹤0.01% |
46,148
-13,002
| -22% | -$118K |
|
1581
Ovintiv
OVV
$16.6B
| $325K | ﹤0.01% |
7,344
| – | – |
|
1582
Bilibili
BILI
$7.47B
| $324K | ﹤0.01% |
12,663
| – | – |
|
|
NTBL
1583
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $322K | ﹤0.01% |
5,714
| – | – |
|
1584
Dentsply Sirona
XRAY
$2.61B
| $318K | ﹤0.01% |
8,879
+274
| +3% | +$11.1K |
|
|
PLL
1585
DELISTED
Piedmont Lithium
PLL
| $316K | ﹤0.01% |
8,690
-6,600
| -43% | -$391K |
|
1586
Sensient Technologies
SXT
$5.32B
| $315K | ﹤0.01% |
3,912
-1,995
| -34% | -$165K |
|
1587
Horace Mann Educators
HMN
$2.09B
| $314K | ﹤0.01% |
8,179
-4,125
| -34% | -$161K |
|
|
QVCGA
1588
DELISTED
QVC Group Inc Series A
QVCGA
| $313K | ﹤0.01% |
2,178
| – | – |
|
1589
Insperity
NSP
$1.92B
| $310K | ﹤0.01% |
3,112
-2,276
| -42% | -$225K |
|
1590
Fortune Brands Innovations
FBIN
$6.14B
| $307K | ﹤0.01% |
5,990
+1,633
| +37% | +$95.7K |
|
1591
Chemed
CHE
$6.76B
| $300K | ﹤0.01% |
640
-51
| -7% | -$24.9K |
|
|
EPZM
1592
DELISTED
Epizyme, Inc
EPZM
| $299K | ﹤0.01% |
203,200
-2,631
| -1% | -$1.93K |
|
1593
Credit Acceptance
CACC
$5.78B
| $298K | ﹤0.01% |
629
+28
| +5% | +$15.5K |
|
1594
United Bankshares
UBSI
$6.57B
| $298K | ﹤0.01% |
8,478
-5,577
| -40% | -$196K |
|
1595
Ero Copper
ERO
$2.73B
| $296K | ﹤0.01% |
35,007
+10,174
| +41% | +$127K |
|
1596
LKQ Corp
LKQ
$6.69B
| $293K | ﹤0.01% |
5,963
-10,133
| -63% | -$499K |
|
1597
New Jersey Resources
NJR
$6.01B
| $293K | ﹤0.01% |
6,575
-4,367
| -40% | -$196K |
|
1598
MKS Inc
MKSI
$21.3B
| $292K | ﹤0.01% |
2,839
-590
| -17% | -$68.7K |
|
1599
Antero Resources
AR
$10.5B
| $291K | ﹤0.01% |
9,508
| – | – |
|
|
VRE
1600
DELISTED
Veris Residential
VRE
| $289K | ﹤0.01% |
18,329
-9,742
| -35% | -$151K |
|
Similar funds
AIMCA
CI
BCIM
VMPIC
EIP
PP
ASRS
CM
Macquarie Group's Q2 2022 Portfolio in Review
As of Q2 2022, Macquarie Group held 2,672 positions worth $89.1B, up 67,641% from $131M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Macquarie Group withdrew a net $3.22B in Q2 2022, closing 108 positions and reducing 853 holdings. Its most notable exit was Healthcare Realty, an estimated $10.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Macquarie Group opened a new position in Petco worth $56.3M.
- Macquarie Group's largest Q2 2022 buy was Petco: 3,818,489 shares worth $56.3M.
- Macquarie Group added most to Hologic in Q2 2022, an estimated $324M increase.
- Macquarie Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $504M.
- Macquarie Group fully exited Healthcare Realty in Q2 2022, selling an estimated $10.8M.
- Macquarie Group's ten largest holdings make up 12% of its $89.1B portfolio in Q2 2022.
- Macquarie Group opened 86 new positions and closed 108 in Q2 2022.
- Macquarie Group's portfolio value rose 67,641% quarter-over-quarter to $89.1B.
Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.